JP2021516957A5 - - Google Patents
Info
- Publication number
- JP2021516957A5 JP2021516957A5 JP2020546320A JP2020546320A JP2021516957A5 JP 2021516957 A5 JP2021516957 A5 JP 2021516957A5 JP 2020546320 A JP2020546320 A JP 2020546320A JP 2020546320 A JP2020546320 A JP 2020546320A JP 2021516957 A5 JP2021516957 A5 JP 2021516957A5
- Authority
- JP
- Japan
- Prior art keywords
- pcpv
- composition
- cancer
- gene
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024001510A JP2024050588A (ja) | 2018-03-07 | 2024-01-09 | パラポックスウイルスベクター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305237.2 | 2018-03-07 | ||
| EP18305237 | 2018-03-07 | ||
| EP18306424.5 | 2018-10-31 | ||
| EP18306424 | 2018-10-31 | ||
| PCT/EP2019/055744 WO2019170820A1 (en) | 2018-03-07 | 2019-03-07 | Parapoxvirus vectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001510A Division JP2024050588A (ja) | 2018-03-07 | 2024-01-09 | パラポックスウイルスベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516957A JP2021516957A (ja) | 2021-07-15 |
| JP2021516957A5 true JP2021516957A5 (cg-RX-API-DMAC7.html) | 2022-03-15 |
Family
ID=65628796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546320A Pending JP2021516957A (ja) | 2018-03-07 | 2019-03-07 | パラポックスウイルスベクター |
| JP2024001510A Pending JP2024050588A (ja) | 2018-03-07 | 2024-01-09 | パラポックスウイルスベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001510A Pending JP2024050588A (ja) | 2018-03-07 | 2024-01-09 | パラポックスウイルスベクター |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12377142B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3762020A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021516957A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112512560A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019229653B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020018117A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3093093A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL277161A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020009262A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019170820A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021258008A1 (en) * | 2020-06-19 | 2021-12-23 | Immunacor Llc | Compositions and methods for treating and preventing viral infection |
| WO2023083951A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory syncytial virus infections |
| WO2024062098A1 (en) | 2022-09-23 | 2024-03-28 | Transgene | Recombinant pseudocowpox virus encoding an interleukin-12 |
| CN116121207B (zh) * | 2023-02-08 | 2025-12-12 | 华南农业大学 | 一种表达猪圆环病毒3型Cap蛋白的重组羊口疮病毒及其制备方法和应用 |
| WO2024178260A2 (en) * | 2023-02-22 | 2024-08-29 | Cornell University | Systems and methods for heterologous gene expression by poxvirus vectors |
| CN116897887A (zh) * | 2023-07-31 | 2023-10-20 | 湖南中医药大学 | 一种病毒性哮喘动物模型的构建方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6222020B1 (en) | 1987-01-07 | 2001-04-24 | Imperial Cancer Research Technology Limited | Antigens derived from the core protein of the human mammary epithelial mucin |
| US5250534A (en) | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
| GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
| FR2668064B1 (fr) | 1990-10-23 | 1994-12-16 | Transgene Sa | Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne. |
| GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| US5856153A (en) | 1994-11-17 | 1999-01-05 | Cayla | Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases |
| AU718141B2 (en) | 1996-02-28 | 2000-04-06 | Bayer Healthcare Ag | Parapoxviruses which contain foreign DNA, their preparation and their use in vaccines |
| AU2182697A (en) | 1996-03-29 | 1997-10-22 | University Of Otago | Parapoxvirus vectors |
| EP0954593A1 (en) | 1996-07-25 | 1999-11-10 | Therion Biologics Corporation | Recombinant pox virus for immunization against tumor-associated antigens |
| CA2282300C (en) | 1997-02-24 | 2011-08-02 | Therion Biologics Corporation | Recombinant pox virus for immunization against muc1 tumor-associated antigen |
| FR2766091A1 (fr) | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
| FR2777570A1 (fr) | 1998-04-17 | 1999-10-22 | Transgene Sa | Mutant ayant une activite phosphoribosyl transferase |
| FR2790955B1 (fr) | 1999-03-19 | 2003-01-17 | Assist Publ Hopitaux De Paris | Utilisation d'oligonucleotides stabilises comme principe actif antitumoral |
| WO2001023001A2 (en) | 1999-09-29 | 2001-04-05 | The Trustees Of The University Of Pennsylvania | Rapid peg-modification |
| US7456009B2 (en) | 2000-03-07 | 2008-11-25 | Merck & Co., Inc. | Adenovirus formulations |
| US7094412B2 (en) | 2001-12-10 | 2006-08-22 | Bavarian Nordic A/S | Poxvirus containing formulations and process for preparing stable poxvirus containing compositions |
| CA2431349A1 (en) * | 2002-06-06 | 2003-12-06 | Xiao-Dan Yao | Method of producing a recombinant virus |
| CA2807534A1 (en) | 2003-02-25 | 2005-02-17 | Medimmune Vaccines, Inc. | Methods of producing influenza vaccine compositions |
| DK1649023T3 (da) | 2003-07-21 | 2008-10-06 | Transgene Sa | Polypeptid med forbedret cytosindeaminaseaktivitet |
| JP4897677B2 (ja) | 2004-07-13 | 2012-03-14 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト | Hiv/aidsの処置用の他の抗ウイルス剤と組み合わせたパラポックスウイルス |
| GB0502661D0 (en) | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
| US20060205080A1 (en) | 2005-03-01 | 2006-09-14 | David Frey | Formulations for therapeutic viruses having enhanced storage stability |
| KR101357685B1 (ko) | 2005-11-21 | 2014-02-06 | 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 | 재조합 바이러스용 안정화 제형 |
| RU2489486C2 (ru) | 2006-06-20 | 2013-08-10 | Трансжене С.А. | Процесс получения поксвирусов и композиции поксвирусов |
| CL2008000249A1 (es) | 2007-01-30 | 2008-05-30 | Transgene Sa | Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus |
| GB0705245D0 (en) | 2007-03-19 | 2007-04-25 | Stabilitech Ltd | Stable biological products |
| PT103865A (pt) | 2007-10-25 | 2009-05-15 | Univ De Coimbra | Nano-transportadores de base lipídica para entrega direccionada de vectores virais e processo para a sua produção |
| DK2212345T3 (en) | 2007-11-19 | 2016-03-21 | Transgene Sa | Oncolytic poxvirus vectors |
| US9222078B2 (en) | 2010-07-01 | 2015-12-29 | Novozymes A/S | Bleaching of pulp |
| PH12013500122A1 (en) | 2010-07-20 | 2017-08-23 | Zoetis Llc | Parapoxvirus vectors |
| TWI575070B (zh) | 2011-07-12 | 2017-03-21 | 傳斯堅公司 | Hbv聚合酶突變體 |
| TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
| US10517943B2 (en) | 2014-12-01 | 2019-12-31 | Transgene S.A. | Stable liquid vaccinia virus formulations |
| CA2975432A1 (en) * | 2015-02-13 | 2016-08-18 | Transgene Sa | Immunotherapeutic vaccine and antibody combination therapy |
| DE102015111756A1 (de) * | 2015-07-20 | 2017-01-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Rekombinanter Orf-Virus-Vektor |
| KR20250067190A (ko) | 2016-08-09 | 2025-05-14 | 시티 오브 호프 | 키메라 폭스바이러스 조성물 및 이의 용도 |
-
2019
- 2019-03-07 CA CA3093093A patent/CA3093093A1/en active Pending
- 2019-03-07 WO PCT/EP2019/055744 patent/WO2019170820A1/en not_active Ceased
- 2019-03-07 BR BR112020018117-0A patent/BR112020018117A2/pt not_active Application Discontinuation
- 2019-03-07 EP EP19708331.4A patent/EP3762020A1/en active Pending
- 2019-03-07 AU AU2019229653A patent/AU2019229653B2/en active Active
- 2019-03-07 US US16/978,219 patent/US12377142B2/en active Active
- 2019-03-07 MX MX2020009262A patent/MX2020009262A/es unknown
- 2019-03-07 JP JP2020546320A patent/JP2021516957A/ja active Pending
- 2019-03-07 CN CN201980030479.4A patent/CN112512560A/zh active Pending
-
2020
- 2020-09-06 IL IL277161A patent/IL277161A/en unknown
-
2024
- 2024-01-09 JP JP2024001510A patent/JP2024050588A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022203309B2 (en) | Recombinant MVA or MVADELE3L expressing human Flt3L and use thereof as immuno-therapeutic agents against solid tumors | |
| US10646557B2 (en) | Vaccine composition | |
| JP6794442B2 (ja) | 新規な遺伝子組換えワクシニアウイルス | |
| US12479918B2 (en) | Plasmid constructs for treating cancer and methods of use | |
| JP7025339B2 (ja) | 癌免疫療法のための、チミジンキナーゼの欠失を伴い、ヒトflt3lまたはgm-csfの発現を伴うかまたは伴わない、複製可能な弱毒化ワクシニアウイルス | |
| JP2024050588A5 (cg-RX-API-DMAC7.html) | ||
| JP7438552B2 (ja) | 注射用医薬品、注射用調製物、および注射用医薬品の製造における使用 | |
| TWI851676B (zh) | 溶瘤病毒用於治療癌症之用途 | |
| CN105031618A (zh) | 用于细胞因子递送的穹窿体复合物 | |
| JP2021533789A5 (cg-RX-API-DMAC7.html) | ||
| CA3073310A1 (en) | Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an antibody | |
| JP2021517814A (ja) | 免疫チェックポイント遮断を発現する癌免疫療法のための腫瘍溶解性ワクシニアウイルス | |
| Shakiba et al. | Recombinant strains of oncolytic vaccinia virus for cancer immunotherapy | |
| CN117797253A (zh) | 一种能扩展t细胞抗原表位的肿瘤疫苗及其制备方法 | |
| WO2024216669A1 (zh) | 具有多种免疫调节因子的增强型溶瘤病毒及其制备方法和应用 | |
| US20230277624A1 (en) | Methods of determining responsiveness to cancer immunotherapy | |
| RU2025100052A (ru) | Рекомбинантный вирус, экспрессирующий интерлейкин-12 | |
| TWI827057B (zh) | 疫苗、其用途及癌症疫苗混合物 | |
| HK40088320A (en) | Use of mva or mvaδe3l as immunotherapeutic agents against solid tumors | |
| CN121653082A (zh) | 一种重组溶瘤痘苗病毒、制备方法及在制备用于预防或治疗肿瘤的药物中的应用 | |
| WO2024062098A1 (en) | Recombinant pseudocowpox virus encoding an interleukin-12 | |
| CN119367516A (zh) | 一种免疫调节因子组合物及其应用 | |
| CN118556081A (zh) | 用于癌症治疗的编码免疫刺激蛋白的重组正痘病毒载体 |